Skip to main content
OpenTrials

Clinical trial condition

Dravet Syndrome

Explore clinical trials studying Dravet Syndrome. Study availability and eligibility vary by location and protocol.

41 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Dravet Syndrome trial results

Active, not recruiting

A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)

NCT06660394

Conditions
Brain Diseases, Central Nervous System Diseases, Dravet Syndrome, +11 more
Locations
  • Austin Hospital Heidelberg, Victoria, Australia
  • Instituto de Neurologia de Curitiba (INC) Curitiba, Paraná, Brazil
  • Hôpital Roger Salengro Lille, Nord, France
  • AP-HP - Hôpital universitaire Robert-Debré Paris, France
View all 105 locations
View Trial Details
Active, not recruiting

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

NCT05044819

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital Abnormalities, +27 more
Locations
  • Clinical Trial Site Little Rock, Arkansas, United States
  • Clinical Trial Site Downey, California, United States
  • Clinical Trial Site Long Beach, California, United States
  • Clinical Trial Site Sacramento, California, United States
View all 26 locations
View Trial Details
Active, not recruiting

Early Check: Expanded Screening in Newborns

NCT03655223

Conditions
17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations
  • RTI International Research Triangle Park, North Carolina, United States
View Trial Details
Active, not recruiting

Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY

NCT05485831

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital Abnormalities, +25 more
Locations
  • Policlinico Sant'Orsola di Bologna Bologna, Italy
  • NPI AOU Mater Domini Università Magna Graecia Catanzaro, Italy
  • Università degli studi "G. D'annunzio" Chieti Chieti, Italy
  • Azienda Ospedaliera Universitaria Meyer Neurologia Pediatrica Florence, Italy
View all 18 locations
View Trial Details
Active, not recruiting

An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome

NCT04740476

Conditions
Brain Diseases, Central Nervous System Diseases, Dravet Syndrome, +5 more
Locations
  • University of California San Francisco Medical Center San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
View all 17 locations
View Trial Details
Active, not recruiting

Neurodevelopmental Impact of Epilepsy on Autonomic Function in Dravet Syndrome

NCT05472389

Conditions
Brain Diseases, Central Nervous System Diseases, Dravet Syndrome, +5 more
Locations
  • Department of Paediatrics and Paediatric Neurology, Antwerp University Hospital Edegem, Belgium
  • HFME Hospices Civils de Lyon Bron, Rhone, France
  • Hôpital Neurologique Pierre Wertheimer Hospices Civils de Lyon Bron, Rhone, France
  • Klinik und Poliklinik für Epileptologie, Universitätsklinikum Bonn, Germany
View Trial Details
Completed

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome

NCT06118255

Conditions
Brain Diseases, Central Nervous System Diseases, Dravet Syndrome, +5 more
Locations
  • Ep0213 105 Memphis, Tennessee, United States
  • Ep0213 107 Dallas, Texas, United States
  • Ep0213 103 Seattle, Washington, United States
  • Ep0213 502 Brussels, Belgium
View Trial Details

Related conditions